We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$18.4B
AUM Growth
+$991M
Cap. Flow
+$652M
Cap. Flow %
3.54%
Top 10 Hldgs %
30.84%
Holding
2,900
New
51
Increased
2,117
Reduced
295
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 30.12%
2 Financials 12.96%
3 Consumer Discretionary 11.52%
4 Healthcare 10.04%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XNCR icon
1451
Xencor
XNCR
$1.71B
$936K 0.01%
40,740
+5,888
+17% +$135K
HEI.A icon
1452
HEICO Corp Class A
HEI.A
$38B
$932K 0.01%
5,006
-114
-2% -$23K
AESI icon
1453
Atlas Energy Solutions
AESI
$1.47B
$928K 0.01%
41,846
+2,308
+6% +$49.7K
SPT icon
1454
Sprout Social
SPT
$604M
$927K 0.01%
30,190
+2,074
+7% +$62.3K
JANX icon
1455
Janux Therapeutics
JANX
$978M
$926K 0.01%
17,298
+949
+6% +$50.2K
TDOC icon
1456
Teladoc Health
TDOC
$1.26B
$924K 0.01%
101,612
+3,108
+3% +$30K
SMR icon
1457
NuScale Power
SMR
$4.04B
$919K 0.01%
51,278
+5,915
+13% +$122K
ENTG icon
1458
Entegris
ENTG
$25B
$919K 0.01%
9,281
-211
-2% -$22.2K
NWN icon
1459
Northwest Natural Holdings
NWN
$2.12B
$915K 0.01%
23,134
+1,555
+7% +$63.4K
DAN icon
1460
Dana Inc
DAN
$3.26B
$914K 0.01%
79,026
+4,531
+6% +$47.1K
ARQT icon
1461
Arcutis Biotherapeutics
ARQT
$3.3B
$912K ﹤0.01%
65,471
+3,813
+6% +$41.8K
WULF icon
1462
TeraWulf
WULF
$8.14B
$911K ﹤0.01%
160,964
+43,388
+37% +$280K
CSGS
1463
DELISTED
CSG Systems International
CSGS
$910K ﹤0.01%
17,809
+1,066
+6% +$54.9K
VECO icon
1464
Veeco
VECO
$3.26B
$910K ﹤0.01%
33,962
+1,887
+6% +$54.8K
VRTS icon
1465
Virtus Investment Partners
VRTS
$1.12B
$910K ﹤0.01%
4,126
+307
+8% +$69.9K
NTCT icon
1466
NETSCOUT
NTCT
$2.87B
$910K ﹤0.01%
41,990
+2,315
+6% +$50.2K
NNI icon
1467
Nelnet
NNI
$4.52B
$909K ﹤0.01%
8,510
+151
+2% +$16.7K
ADEA icon
1468
Adeia
ADEA
$3.16B
$909K ﹤0.01%
64,990
+1,804
+3% +$22.8K
HLIO icon
1469
Helios Technologies
HLIO
$2.66B
$908K ﹤0.01%
20,338
+1,116
+6% +$55.2K
SASR
1470
DELISTED
Sandy Spring Bancorp Inc
SASR
$907K ﹤0.01%
26,914
+2,107
+8% +$73.5K
AAOI icon
1471
Applied Optoelectronics
AAOI
$11B
$904K ﹤0.01%
24,528
+2,963
+14% +$79.7K
GSAT icon
1472
Globalstar
GSAT
$10.8B
$904K ﹤0.01%
29,103
+4,868
+20% +$120K
NWS icon
1473
News Corp Class B
NWS
$17.7B
$903K ﹤0.01%
29,660
+450
+2% +$13.6K
GNL icon
1474
Global Net Lease
GNL
$1.9B
$902K ﹤0.01%
123,623
+7,818
+7% +$60K
NGVT icon
1475
Ingevity
NGVT
$2.62B
$900K ﹤0.01%
22,088
+1,206
+6% +$50.2K

Similar funds

MetLife Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, MetLife Investment Management held 2,900 positions worth $18.4B, up 5.7% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

MetLife Investment Management deployed $652M of net new capital in Q4 2024, opening 51 new positions and adding to 2,117 existing holdings. Its largest new stake was Flex: 211,786 shares worth $8.13M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Arista Networks, an estimated $13.8M trimmed.

  • MetLife Investment Management's largest Q4 2024 buy was Flex: 211,786 shares worth $8.13M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $117M increase.
  • MetLife Investment Management's biggest Q4 2024 reduction was Arista Networks, cutting an estimated $13.8M.
  • MetLife Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $4.05M.
  • MetLife Investment Management's ten largest holdings make up 31% of its $18.4B portfolio in Q4 2024.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q4 2024.
  • MetLife Investment Management's portfolio value rose 5.7% quarter-over-quarter to $18.4B.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.